GLUU Glu Mobile Inc.

Mike Olsen Joins Glu as Senior Vice President of Studios

Glu Mobile Inc. (NASDAQ:GLUU), a leading global developer and publisher of free-to-play mobile games, today announced that Mike Olsen has joined the company as Senior Vice President of Studios. Olsen brings an extensive background in creative direction, game design, studio management and live game operations. He joins a strong team of existing leaders at Glu as the company looks to a successful future driven by highly creative and proven leaders.

“I am incredibly pleased to welcome Mike Olsen as Glu’s SVP of Studios where he’ll build a talented team of developers to create innovative new products,” said Nick Earl, Glu’s President and CEO. "As I enter my first year leading the company, I plan to invest in and empower leaders with the same industry prowess as Mike."

“Glu’s talent model is focused on hiring the industry’s finest and arming them with world-class infrastructure, tools, funding and support to create phenomenal products while eliminating the risk of going at it alone,” continued Earl. "It’s under the guidance of experienced and fearless creative leaders that I believe Glu will deliver best-in-class entertainment products in 2017 and beyond.”

“As a leading developer of mobile games for over a decade, Glu’s industry-leading success is something I’ve recognized for quite a while,” said Olsen. “I am tremendously excited to join the Glu team to apply my breadth of game development experience to drive the company’s product innovation into high-gear.”

A twenty-year industry veteran spanning mobile, console, online and PC gaming, Olsen joins Glu from Electronic Arts where he most recently led the Capital Games studio in Sacramento, California. During his tenure at EA, Olsen served in various roles where he led the design and creative direction for 25 titles including Star Wars: Galaxy of Heroes, The Godfather, Tiger Woods PGA Tour Golf, NCAA March Madness, NCAA Football, Knockout Kings, Dungeon Keeper and more. Star Wars: Galaxy of Heroes has been downloaded over 30 million times, has generated more than $100 million in revenue and received Apple’s Editor’s Choice and Google’s Best Picks. Olsen has been honored as an EA inventor, having been named as a co-inventor on three registered patents for his work with the company.

Cautions Regarding Forward-Looking Statements

This press release contains certain “forward-looking statements” related to the business of Glu Mobile Inc., including statements regarding: the company looks to a successful future driven by highly creative and proven leaders; Mr. Olsen will build a talented team of developers to create innovative new products; Glu plans to invest in and empower leaders with the same industry prowess as Mr. Olsen; Glu’s talent model is focused on hiring the industry’s finest and arming them with world-class infrastructure, tools, funding and support to create phenomenal products while eliminating the risk of going at it alone; we believe Glu will deliver best-in-class platform entertainment products in 2017 and beyond; and that Mr. Olsen is tremendously excited to join the Glu team to apply his breadth of game development experience to drive the company’s product innovation into high-gear. Such forward-looking statements involve known and unknown risks and uncertainties, including, but not limited to, the risk that we do not realize the expected benefits from our hiring of Mr. Olsen; the risk that consumer demand for smartphones, tablets and next-generation platforms does not grow as significantly as we anticipate or that we will be unable to capitalize on any such growth; the risk that we do not realize a sufficient return on our investment with respect to our efforts to develop free-to-play games for smartphones, tablets and next-generation platforms; and the risk that our recently and newly launched games are less popular than anticipated or decline in popularity and monetization rates more quickly than we anticipate. Certain of these risks and uncertainties are or will be described in greater detail in our public filings with the SEC. Glu is not under obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

About Glu Mobile

Glu Mobile (NASDAQ:GLUU) is a leading global developer and publisher of free-to-play mobile games. Glu is focused on creating compelling original IP games such as CONTRACT KILLER, COOKING DASH, COVET FASHION, DEER HUNTER, DESIGN HOME, QUIZUP, RACING RIVALS, and TAP SPORTS BASEBALL, and branded IP games including GORDON RAMSAY DASH, KENDALL & KYLIE, and KIM KARDASHIAN: HOLLYWOOD on the App Store, Google Play and Amazon Appstore. Founded in 2001, Glu is headquartered in San Francisco with U.S. offices outside Seattle and in Burlingame, San Mateo, Long Beach and Portland, and international locations in Canada, China, India, Japan, and Russia. Consumers can find high-quality entertainment wherever they see the ‘g’ character logo or at www.glu.com.

For live updates, please follow Glu via Twitter at www.twitter.com/glumobile and on Instagram at www.instagram.com/glumobile, or become a Glu fan at www.facebook.com/glumobile.

CONTRACT KILLER, COOKING DASH, COVET FASHION, DEER HUNTER, QUIZUP, RACING RIVALS, TAP SPORTS, GLU, GLU MOBILE, and the 'g' character logo are trademarks of Glu Mobile Inc.

EN
26/01/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Glu Mobile Inc.

Wedbush Research
  • Wedbush Research
2454 MEDIATEK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
BLUE BLUEBIRD BIO INC.
XOMA XOMA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TPH TRI POINTE HOMES INC.
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
LGIH LGI HOMES INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
KBH KB HOME
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
SWKS SKYWORKS SOLUTIONS INC.
DOOR MASONITE INTERNATIONAL CORP.
5425 TAIWAN SEMICONDUCTOR CO. LTD.
7974 NINTENDO CO. LTD.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
GLUU GLU MOBILE INC.
TMHC TAYLOR MORRISON HOME CORPORATION
ZNGA ZYNGA INC. CLASS A
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ANGI ANGI INC. CLASS A
ARGX ARGEN-X SE
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
RGLS REGULUS THERAPEUTICS
TCRR TCR2 THERAPEUTICS
LYFT LYFT
ORTX ORCHARD RX ADS
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
UBER UBER TECHNOLOGIES INC.
IMUX IMMUNIC INC
SCPL SCIPLAY
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
FUSN INC.
U FUSION PHARMACEUTICALS INC
ACET UNITY SOFTWARE INC.
GRAY ADICET BIO
PASG INC
IAC GRAYBUG VISION
FRLN INC
ITOS PASSAGE BIO
INZY IAC/INTERACTIVECORP.
CDAK FREELINE THERAPEUTICS HOLDINGS ADS
ZNTL ITEOS THERAPEUTICS
BEAM INOZYME PHARMA
GBIO CODIAK BIOSCIENCES
PRAX INC.
FHTX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX GENERATION BIO
KNTE PRAXIS PRECISION MEDICINES
SKLZ FOGHORN THERAPEUTICS
PLTK INC.
COGENT BIOSCIENCES INC
TRAVERE THERAPEUTICS INC
KINNATE BIOPHARMA
SKILLZ INC (A)
PLAYTIKA HOLDING
Wedbush Research
  • Wedbush Research
2454 MEDIATEK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
HZO MARINEMAX INC.
BLUE BLUEBIRD BIO INC.
XOMA XOMA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NUAN NUANCE COMMUNICATIONS INC.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
ACOR ACORDA THERAPEUTICS INC.
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
BC BRUNSWICK CORPORATION
SWKS SKYWORKS SOLUTIONS INC.
5425 TAIWAN SEMICONDUCTOR CO. LTD.
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
GLUU GLU MOBILE INC.
ZNGA ZYNGA INC. CLASS A
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ARGX ARGEN-X SE
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
RGLS REGULUS THERAPEUTICS
TCRR TCR2 THERAPEUTICS
ORTX ORCHARD RX ADS
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
IMUX IMMUNIC INC
SCPL SCIPLAY
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
FUSN INC.
ACET FUSION PHARMACEUTICALS INC
GRAY ADICET BIO
PASG INC
FRLN GRAYBUG VISION
ITOS INC
INZY PASSAGE BIO
CDAK FREELINE THERAPEUTICS HOLDINGS ADS
ZNTL ITEOS THERAPEUTICS
BEAM INOZYME PHARMA
GBIO CODIAK BIOSCIENCES
PRAX INC.
FHTX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX GENERATION BIO
KNTE PRAXIS PRECISION MEDICINES
PLTK FOGHORN THERAPEUTICS
INC.
COGENT BIOSCIENCES INC
TRAVERE THERAPEUTICS INC
KINNATE BIOPHARMA
PLAYTIKA HOLDING

ResearchPool Subscriptions

Get the most out of your insights

Get in touch